ClinicalTrials.gov
ClinicalTrials.gov Menu

Follow up of Patients Treated With Cognitive Behavioural Therapy for Hypochondria From 1997 to 2007

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00959452
Recruitment Status : Active, not recruiting
First Posted : August 14, 2009
Last Update Posted : November 9, 2016
Sponsor:
Information provided by (Responsible Party):
Ingvard Wilhelmsen, University of Bergen

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Research has shown that cognitive behavioural therapy is effective in treating hypochondria. However, no studies have examined the long term effect. The investigators have followed 56 patients treated for hypochondria between 1997 and 2001 and the investigators are now doing a 10 year follow-up (Part I). In another part of the study (Part II) the investigators compare the effect of 16 sessions vs. 5 sessions, with a follow-up period of at least 2 years. The investigators hypothesis is that the initial 1 year improvement will be sustained and that 5 sessions will yield the same results as 16 sessions.

Condition or disease Intervention/treatment Phase
Hypochondriasis Behavioral: Cognitive behavioural therapy Not Applicable

Detailed Description:

The follow-up includes a telephone interview by independent researcher and the patients fill in the following questionnaires:

Whiteley Index (measures health anxiety), VAS-scales for health anxiety, worrying about symptoms and body checking, SF-36 (health related quality of life), Giessen Subjective Complaints List, Spielberger Trait and State Anxiety Scale Beck Depression Inventory, Eysenck Personality Questionnaire, General Health Questionnaire (GHQ 28), Somatic Amplification Scale,


Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 250 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Follow up of Patients Treated With Cognitive Behavioural Therapy at Clinic for Hypochondriacs, Haraldsplass Deaconal Hospital, From 1997 to 2007
Study Start Date : January 1997
Actual Primary Completion Date : December 2010
Estimated Study Completion Date : December 2017
Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Psychotherapy Behavioral: Cognitive behavioural therapy
16 sessions vs 5 sessions of cognitive behavioural therapy
Other Name: Cognitive therapy


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Level of health anxiety [ Time Frame: 10 years follow up ]

Secondary Outcome Measures :
  1. Health related quality of life [ Time Frame: 10 years follow-up ]

Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Fulfilling ICD-10 criteria for hypochondriacal disorder

Exclusion Criteria:

  • Unwillingness to participate
  • Substance abuse
  • Serious psychological (f.inst. psychosis, major depression) or somatic (f.inst. cancer) disease
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00959452


Locations
Norway
Haraldsplass Deaconal Hospital
Bergen, Norway, 5009
Sponsors and Collaborators
University of Bergen
Investigators
Principal Investigator: Ingvard Wilhelmsen, PhD University of Bergen
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications of Results:

Responsible Party: Ingvard Wilhelmsen, Professor, University of Bergen
ClinicalTrials.gov Identifier: NCT00959452     History of Changes
Other Study ID Numbers: 17242
First Posted: August 14, 2009    Key Record Dates
Last Update Posted: November 9, 2016
Last Verified: November 2016

Keywords provided by Ingvard Wilhelmsen, University of Bergen:
Hypochondria
Cognitive behavioural therapy
Long term follow-up
Psychosomatics
Psychotherapy

Additional relevant MeSH terms:
Hypochondriasis
Somatoform Disorders
Mental Disorders